These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 21411701)
1. Interferon-α/β receptor as a prognostic marker in osteosarcoma. Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431 [TBL] [Abstract][Full Text] [Related]
3. Commentary on an article by Tadahiko Kubo, MD, PhD, et al.: "Interferon-α/β receptor as a prognostic marker in osteosarcoma". Reith JD J Bone Joint Surg Am; 2011 Mar; 93(6):e24. PubMed ID: 21411699 [No Abstract] [Full Text] [Related]
5. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700 [TBL] [Abstract][Full Text] [Related]
6. Vitronectin significantly influences prognosis in osteosarcoma. Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861 [TBL] [Abstract][Full Text] [Related]
7. Improved survival in osteosarcoma patients with atypical low vascularization. Kunz P; Fellenberg J; Moskovszky L; Sápi Z; Krenacs T; Machado I; Poeschl J; Lehner B; Szendrõi M; Ruef P; Bohlmann M; Bosch AL; Ewerbeck V; Kinscherf R; Fritzsching B Ann Surg Oncol; 2015 Feb; 22(2):489-96. PubMed ID: 25155396 [TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic relevance of centromere protein A in primary osteosarcoma. Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098 [TBL] [Abstract][Full Text] [Related]
9. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma? Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692 [TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma. Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553 [TBL] [Abstract][Full Text] [Related]
11. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response. Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104 [TBL] [Abstract][Full Text] [Related]
12. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience. Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713 [TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma. Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921 [TBL] [Abstract][Full Text] [Related]
16. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705 [TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma. Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071 [TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123 [TBL] [Abstract][Full Text] [Related]
19. XB130 expression in human osteosarcoma: a clinical and experimental study. Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762 [TBL] [Abstract][Full Text] [Related]
20. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma. Feng H; Guo P; Wang J; Xu J; Xie C; Gao F Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]